629 related articles for article (PubMed ID: 17544165)
1. Lipid nanoparticles for improved topical application of drugs for skin diseases.
Schäfer-Korting M; Mehnert W; Korting HC
Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
Pardeike J; Hommoss A; Müller RH
Int J Pharm; 2009 Jan; 366(1-2):170-84. PubMed ID: 18992314
[TBL] [Abstract][Full Text] [Related]
4. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.
Küchler S; Herrmann W; Panek-Minkin G; Blaschke T; Zoschke C; Kramer KD; Bittl R; Schäfer-Korting M
Int J Pharm; 2010 May; 390(2):225-33. PubMed ID: 20153414
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers (NLC) in cosmetic dermal products.
Müller RH; Petersen RD; Hommoss A; Pardeike J
Adv Drug Deliv Rev; 2007 Jul; 59(6):522-30. PubMed ID: 17602783
[TBL] [Abstract][Full Text] [Related]
7. Skin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogel.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2005 Oct; 60(10):751-5. PubMed ID: 16259122
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles.
Küchler S; Radowski MR; Blaschke T; Dathe M; Plendl J; Haag R; Schäfer-Korting M; Kramer KD
Eur J Pharm Biopharm; 2009 Feb; 71(2):243-50. PubMed ID: 18796329
[TBL] [Abstract][Full Text] [Related]
10. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin.
Jensen LB; Petersson K; Nielsen HM
Eur J Pharm Biopharm; 2011 Sep; 79(1):68-75. PubMed ID: 21664463
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
Wong HL; Bendayan R; Rauth AM; Li Y; Wu XY
Adv Drug Deliv Rev; 2007 Jul; 59(6):491-504. PubMed ID: 17532091
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
13. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
Lauterbach A; Müller-Goymann CC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
[TBL] [Abstract][Full Text] [Related]
14. Carriers in the topical treatment of skin disease.
Korting HC; Schäfer-Korting M
Handb Exp Pharmacol; 2010; (197):435-68. PubMed ID: 20217539
[TBL] [Abstract][Full Text] [Related]
15. Structure and dynamics of drug-carrier systems as studied by parelectric spectroscopy.
Blaschke T; Kankate L; Kramer KD
Adv Drug Deliv Rev; 2007 Jul; 59(6):403-10. PubMed ID: 17573146
[TBL] [Abstract][Full Text] [Related]
16. Cosmetic features and applications of lipid nanoparticles (SLN, NLC).
Souto EB; Müller RH
Int J Cosmet Sci; 2008 Jun; 30(3):157-65. PubMed ID: 18452432
[TBL] [Abstract][Full Text] [Related]
17. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M
Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
Souto EB; Müller RH
Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
[TBL] [Abstract][Full Text] [Related]
19. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
Souto EB; Wissing SA; Barbosa CM; Müller RH
Int J Pharm; 2004 Jun; 278(1):71-7. PubMed ID: 15158950
[TBL] [Abstract][Full Text] [Related]
20. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
Weber S; Zimmer A; Pardeike J
Eur J Pharm Biopharm; 2014 Jan; 86(1):7-22. PubMed ID: 24007657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]